KRT14 and head and neck squamous cell carcinoma: By targeting cytokeratin 14 RNA with ultrabright SERS nanorattles, we demonstrated the capability of our method in distinguishing HNSCC from other tissue types such as thyroid cancer and benign lymphoid tissue.